Report
Dawid Górzyński

Krka - 1Q19 conference call – growth drivers remain unclear (neutral)

Research prepared by PKO BP Securities
Underlying
KRKA d.d.

Krka is a public generic pharmaceutical company based in Slovenia. Co. is engaged in the development, production, sale and marketing of human health products (prescription and selfmedication pharmaceuticals and cosmetics), animal health products and health resort and tourist services. Co. focuses on a range of generic prescription pharmaceuticals, which are marketed under Co.'s own brands. Co. offers customers in over 70 countries a broad range of prescription pharmaceuticals, self-medication products and animal health and cosmetic products. Co.'s activities are supplemented by health resort and tourist services of Terme Krka.

Provider
PKO Bank Polski
PKO Bank Polski

Analysts
Dawid Górzyński

Other Reports on these Companies
Other Reports from PKO Bank Polski

ResearchPool Subscriptions

Get the most out of your insights

Get in touch